No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
Analysts Offer Insights on Healthcare Companies: Poseida Therapeutics (PSTX), Greenwich LifeSciences (GLSI) and ACELYRIN, INC. (SLRN)
Express News | HC Wainwright & Co. Maintains Buy on Acelyrin, Raises Price Target to $18
Express News | HC Wainwright & Co. Reiterates Buy on Acelyrin, Maintains $16 Price Target
Buy Rating Affirmed for ACELYRIN, INC. on Solid Financials and Promising Pipeline
ACELYRIN, INC.: Strong Buy Recommendation on Promising Izo Drug Prospects and Strategic Advancements
Acelyrin | 10-Q: Quarterly report
No Data
diamonds : 请问,ENDPQ重组后,持有的股票还能有效吗?